Evidence map›Paper›PMID 40943408›Full record

ArticleInternational journal of molecular sciences2025

Mizuki Tokusanai, Koichiro Tateishi, Kanako Hirata, Nahoko Fukunishi, Yusuke Suzuki, Ryohei Kono, Sorama Natsumi, Chikara Kato, Susumu Takekoshi, Yoshiharu Okuno and 2 more

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correction: Tokusanai et al.International journal of molecular sciences · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Mizuki TokusanaiDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Koichiro TateishiDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Kanako HirataDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Nahoko FukunishiDepartment of Life Science Support, Research Innovation Center, University Hospitals Sector, Tokai University, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Yusuke SuzukiDepartment of Life Science Support, Research Innovation Center, University Hospitals Sector, Tokai University, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Ryohei KonoDepartment of Rehabilitation, Osaka Kawasaki Rehabilitation University, 158 Mizuma, Kaizuka 597-0104, Osaka, Japan.ORCID 0000-0002-9354-1759
Sorama NatsumiDepartment of Applied Chemistry and Biochemistry, National Institute of Technology, Wakayama College, 77 Noshima, Nada, Gobo 644-0023, Wakayama, Japan.
Chikara KatoDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Susumu TakekoshiDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
Yoshiharu OkunoDepartment of Applied Chemistry and Biochemistry, National Institute of Technology, Wakayama College, 77 Noshima, Nada, Gobo 644-0023, Wakayama, Japan.ORCID 0000-0003-4422-9547
Hirotoshi UtsunomiyaDepartment of Rehabilitation, Osaka Kawasaki Rehabilitation University, 158 Mizuma, Kaizuka 597-0104, Osaka, Japan.
Norio YamamotoDepartment of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.

Funding

Japan Society for the Promotion of Science JSPS KAKENHI grant number 19K08962Minabecho Minabecho Collaborative Research Project grant number 24A037000Tokai University Research and Study Project of Tokai University grant number PJ2021-02Tokai University Tokai University School of Medicine Project Research grant number 2021-01
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus are major respiratory pathogens associated with substantial morbidity and a risk of severe disease. However, the effectiveness of current vaccines and antiviral drugs is limited by viral mutations. Umeboshi, a traditional Japanese food prepared from pickled

Indexed as

Antiviral AgentsPlant ExtractsPrunusSARS-CoV-2VirionAnimalsChlorocebus aethiopsCOVID-19COVID-19 Drug TreatmentDogsHumansMadin Darby Canine Kidney CellsVero CellsVirus ReplicationAntiviral AgentsPlant Extractsantiviral activityinfluenza virusPrunus mumeSARS-CoV-2Umeboshiviral inactivationvirucidal mechanism

Identifiers

PMID40943408
PMCPMC12428777

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.